id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT02908906
29:61:treatment
Treatment with any local or systemic anti-neoplastic therapy
2
[ "Treatment", "with", "any", "local", "or", "systemic", "anti-neoplastic", "therapy" ]
[ 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT02592551
23:31:treatment,,119:127:treatment,131:150:treatment
Receipt of drugs with laxative properties and herbal or natural remedies for constipation within 90 days of receiving MEDI4736 or MEDI + tremelimumab
2
[ "Receipt", "of", "drugs", "with", "laxative", "properties", "and", "herbal", "or", "natural", "remedies", "for", "constipation", "within", "90", "days", "of", "receiving", "MEDI4736", "or", "MEDI", "+", "tremelimumab" ]
[ 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 1 ]
NCT02503722
18:36:chronic_disease
Prior history of corneal ulceration
2
[ "Prior", "history", "of", "corneal", "ulceration" ]
[ 0, 0, 0, 2, 2 ]
NCT01946074
17:36:treatment,64:72:treatment,77:94:treatment
Subjects in the combination therapy cohorts who are to receive ABBV-181, an anti-PD1 antibody, must also meet other criteria described in the Protocol
2
[ "Subjects", "in", "the", "combination", "therapy", "cohorts", "who", "are", "to", "receive", "ABBV-181", ",", "an", "anti-PD1", "antibody", ",", "must", "also", "meet", "other", "criteria", "described", "in", "the", "Protocol" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02309580
29:60:treatment,
Patients who have undergone allogeneic stem cell transplant > 12 months
2
[ "Patients", "who", "have", "undergone", "allogeneic", "stem", "cell", "transplant", ">", "12", "months" ]
[ 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0 ]
NCT02019641
25:40:treatment
Active participation in ILD drug trials
2
[ "Active", "participation", "in", "ILD", "drug", "trials" ]
[ 0, 0, 0, 1, 1, 1 ]
NCT02924402
25:34:chronic_disease,36:41:chronic_disease,43:82:chronic_disease,
Evidence of any serious bacterial, viral, parasitic or systemic fungal infections within the 30 days prior to study entry
2
[ "Evidence", "of", "any", "serious", "bacterial", ",", "viral", ",", "parasitic", "or", "systemic", "fungal", "infections", "within", "the", "30", "days", "prior", "to", "study", "entry" ]
[ 0, 0, 0, 0, 2, 0, 2, 0, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02584244
17:23:cancer
Subjects at any cancer stage will be enrolled
2
[ "Subjects", "at", "any", "cancer", "stage", "will", "be", "enrolled" ]
[ 0, 0, 0, 3, 0, 0, 0, 0 ]
NCT02361554
,70:80:treatment
Subject is able to read English, understand and cooperate with study procedures, and has signed a written informed consent form prior to any study procedures
2
[ "Subject", "is", "able", "to", "read", "English", ",", "understand", "and", "cooperate", "with", "study", "procedures", ",", "and", "has", "signed", "a", "written", "informed", "consent", "form", "prior", "to", "any", "study", "procedures" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02525692
27:44:treatment,60:104:treatment,134:143:treatment,
Concomitant use of potent CYP3A4/5 inducers, which include enzyme inducing antiepileptic drugs (EIAEDs) (see Appendix B), during the treatment phase of the study and within 2 weeks prior to starting treatment
2
[ "Concomitant", "use", "of", "potent", "CYP3A4/5", "inducers", ",", "which", "include", "enzyme", "inducing", "antiepileptic", "drugs", "(", "EIAEDs", ")", "(", "see", "Appendix", "B", ")", ",", "during", "the", "treatment", "phase", "of", "the", "study", "an...
[ 0, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03080142
33:51:treatment
Patients scheduled for elective colorectal surgery with Dr. Linda Farkas
2
[ "Patients", "scheduled", "for", "elective", "colorectal", "surgery", "with", "Dr.", "Linda", "Farkas" ]
[ 0, 0, 0, 0, 1, 1, 0, 0, 0, 0 ]
NCT03157492
,45:47:treatment
Greater than three years post-activation of CI
2
[ "Greater", "than", "three", "years", "post-activation", "of", "CI" ]
[ 0, 0, 0, 0, 0, 0, 1 ]
NCT01996449
1:14:treatment
phenylephrine
2
[ "phenylephrine" ]
[ 1 ]
NCT02457845
1:34:treatment
Autologous bone marrow transplant
2
[ "Autologous", "bone", "marrow", "transplant" ]
[ 1, 1, 1, 1 ]
NCT00492778
1:31:chronic_disease,,
Neuropathy (sensory and motor) =< CTCAE v 3.0 grade 1
2
[ "Neuropathy", "(", "sensory", "and", "motor", ")", "=", "<", "CTCAE", "v", "3.0", "grade", "1" ]
[ 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03088033
21:29:treatment,,
Currently requiring dialysis; or estimated-GFR <25ml/min/1.73 m2 by CKD-Epi equation
2
[ "Currently", "requiring", "dialysis", ";", "or", "estimated-GFR", "<", "25ml/min/1.73", "m2", "by", "CKD-Epi", "equation" ]
[ 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02641093
11:29:cancer
Confirmed metastatic disease
2
[ "Confirmed", "metastatic", "disease" ]
[ 0, 3, 3 ]
NCT02312596
1:6:chronic_disease,39:60:treatment,68:72:treatment
Ulcer expected to be treated with any advanced therapeutics (e.g., HBOT)
2
[ "Ulcer", "expected", "to", "be", "treated", "with", "any", "advanced", "therapeutics", "(", "e.g.", ",", "HBOT", ")" ]
[ 2, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 1, 0 ]
NCT01869114
33:44:treatment,48:58:treatment,96:99:chronic_disease
Patient may have previously had azacitidine or decitabine will be eligible to enroll on Arm A (MDS)
2
[ "Patient", "may", "have", "previously", "had", "azacitidine", "or", "decitabine", "will", "be", "eligible", "to", "enroll", "on", "Arm", "A", "(", "MDS", ")" ]
[ 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0 ]
NCT02415556
1:9:chronic_disease,,
Dementia (Mini Mental State Examination [MMSE] scores ≤20)
2
[ "Dementia", "(", "Mini", "Mental", "State", "Examination", "[", "MMSE", "]", "scores", "≤20", ")" ]
[ 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02378428
88:105:treatment
Patients with disease of any major organ system that would compromise their ability to withstand therapy
2
[ "Patients", "with", "disease", "of", "any", "major", "organ", "system", "that", "would", "compromise", "their", "ability", "to", "withstand", "therapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT01620216
5:36:cancer,38:53:treatment,58:73:treatment,86:94:treatment,99:107:treatment,111:120:treatment,124:133:treatment
for Philadelphia positive (Ph+) ALL, initial therapy and salvage therapy may include steroids and imatinib or dasatinib or nilotinib
2
[ "for", "Philadelphia", "positive", "(", "Ph+", ")", "ALL", ",", "initial", "therapy", "and", "salvage", "therapy", "may", "include", "steroids", "and", "imatinib", "or", "dasatinib", "or", "nilotinib" ]
[ 0, 3, 3, 3, 3, 0, 0, 0, 1, 1, 0, 1, 1, 0, 0, 1, 0, 1, 0, 1, 0, 1 ]
NCT02385110
33:61:chronic_disease
A documentation of diagnosis of hemophagocytic lymphocytosis, either newly diagnosed or relapsed/refractory by the treating physician and the PI in the patients chart
2
[ "A", "documentation", "of", "diagnosis", "of", "hemophagocytic", "lymphocytosis", ",", "either", "newly", "diagnosed", "or", "relapsed/refractory", "by", "the", "treating", "physician", "and", "the", "PI", "in", "the", "patients", "chart" ]
[ 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02021578
24:43:chronic_disease
Current diagnosis of a depressive disorder (child)
2
[ "Current", "diagnosis", "of", "a", "depressive", "disorder", "(", "child", ")" ]
[ 0, 0, 0, 0, 2, 2, 0, 0, 0 ]
NCT02095808
1:14:chronic_disease
Heart failure
2
[ "Heart", "failure" ]
[ 2, 2 ]
NCT02243813
,157:173:chronic_disease
Current or past history within the last 5 years of meeting DSM-5 criteria for alcohol or substance use disorder (excluding caffeine and nicotine) or severe major depression
2
[ "Current", "or", "past", "history", "within", "the", "last", "5", "years", "of", "meeting", "DSM-5", "criteria", "for", "alcohol", "or", "substance", "use", "disorder", "(", "excluding", "caffeine", "and", "nicotine", ")", "or", "severe", "major", "depression"...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT02576444
13:19:cancer
Progressive cancer at the time of study entry
2
[ "Progressive", "cancer", "at", "the", "time", "of", "study", "entry" ]
[ 0, 3, 0, 0, 0, 0, 0, 0 ]
NCT02578641
5:11:cancer,
any cancer curatively treated >3 years prior to study entry
2
[ "any", "cancer", "curatively", "treated", ">", "3", "years", "prior", "to", "study", "entry" ]
[ 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02138617
20:37:treatment
Willing to undergo UGT1A1 genotyping
2
[ "Willing", "to", "undergo", "UGT1A1", "genotyping" ]
[ 0, 0, 0, 1, 1 ]
NCT02011971
18:36:treatment
Use of centrally active medications
2
[ "Use", "of", "centrally", "active", "medications" ]
[ 0, 0, 0, 1, 1 ]
NCT02158234
13:31:cancer
Evidence of distant metastases
2
[ "Evidence", "of", "distant", "metastases" ]
[ 0, 0, 3, 3 ]
NCT02046330
,128:142:treatment,,201:208:treatment,210:212:treatment,214:224:treatment,226:238:treatment,240:255:treatment,257:266:treatment,273:302:treatment
adequate trials ( equal>4 weeks at the usually recommended or maximum tolerated dose) of augmentation/combination of a primary antidepressant using at least 2 different augmenting/combination agents (lithium, T3, stimulants, neuroleptics, anticonvulsants, buspirone, or a second primary antidepressant)
2
[ "adequate", "trials", "(", "equal", ">", "4", "weeks", "at", "the", "usually", "recommended", "or", "maximum", "tolerated", "dose", ")", "of", "augmentation/combination", "of", "a", "primary", "antidepressant", "using", "at", "least", "2", "different", "augmenti...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0, 1, 0, 1, 0, 1, 0, 0, 0, 1, 1, 1, 0 ]
NCT01908777
19:22:treatment,47:94:chronic_disease,96:115:chronic_disease,120:131:chronic_disease,,
Other significant ECG abnormalities including 2nd degree atrio-ventricular (AV) block type II, 3rd degree AV block, or bradycardia (ventricular rate less than 50 beats/min)
2
[ "Other", "significant", "ECG", "abnormalities", "including", "2nd", "degree", "atrio-ventricular", "(", "AV", ")", "block", "type", "II", ",", "3rd", "degree", "AV", "block", ",", "or", "bradycardia", "(", "ventricular", "rate", "less", "than", "50", "beats/mi...
[ 0, 0, 1, 0, 0, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 2, 2, 2, 2, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01553071
1:18:treatment,20:32:treatment,,,94:105:treatment,109:120:treatment,140:151:treatment,154:162:treatment
Radiation therapy, chemotherapy, and other investigational agents within 3weeks (6 weeks for nitrosourea or mitomycin C) prior to starting fenretinide + safingol
2
[ "Radiation", "therapy", ",", "chemotherapy", ",", "and", "other", "investigational", "agents", "within", "3weeks", "(", "6", "weeks", "for", "nitrosourea", "or", "mitomycin", "C", ")", "prior", "to", "starting", "fenretinide", "+", "safingol" ]
[ 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 1, 0, 1 ]
NCT02437370
6:24:chronic_disease
Have measurable disease based on Response Evaluation Criteria in Solid Tumors (RECIST) 1.1
2
[ "Have", "measurable", "disease", "based", "on", "Response", "Evaluation", "Criteria", "in", "Solid", "Tumors", "(", "RECIST", ")", "1.1" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03113695
,,,,,166:175:treatment
Females of childbearing potential (FCBP) must have a negative serum or urine pregnancy test within 10 - 14 days prior to and again within 24 hours prior to starting REVLIMID®
2
[ "Females", "of", "childbearing", "potential", "(", "FCBP", ")", "must", "have", "a", "negative", "serum", "or", "urine", "pregnancy", "test", "within", "10", "-", "14", "days", "prior", "to", "and", "again", "within", "24", "hours", "prior", "to", "startin...
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
NCT01660607
1:29:chronic_disease
Myeloproliferative syndromes
2
[ "Myeloproliferative", "syndromes" ]
[ 2, 2 ]
NCT02341287
,,,144:160:treatment,168:178:treatment
Have difficulty initiating sleep for at least two-weeks, including a sleep latency of at least 30-minutes, three days per week (as measured by wrist actigraphy and/or sleep logs)
2
[ "Have", "difficulty", "initiating", "sleep", "for", "at", "least", "two-weeks", ",", "including", "a", "sleep", "latency", "of", "at", "least", "30-minutes", ",", "three", "days", "per", "week", "(", "as", "measured", "by", "wrist", "actigraphy", "and/or", "...
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0 ]
NCT02378428
,,78:95:treatment
the presence of a partial response (PR) with high Curie score (>2) following induction therapy
2
[ "the", "presence", "of", "a", "partial", "response", "(", "PR", ")", "with", "high", "Curie", "score", "(", ">", "2", ")", "following", "induction", "therapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02556606
12:25:chronic_disease,27:51:chronic_disease,59:77:chronic_disease,82:98:chronic_disease
History of schizophrenia, schizoaffective disorder or any psychotic disorder, or bipolar disorder
2
[ "History", "of", "schizophrenia", ",", "schizoaffective", "disorder", "or", "any", "psychotic", "disorder", ",", "or", "bipolar", "disorder" ]
[ 0, 0, 2, 0, 2, 2, 0, 0, 2, 2, 0, 0, 2, 2 ]
NCT02274116
12:28:treatment
concurrent physical therapy
2
[ "concurrent", "physical", "therapy" ]
[ 0, 1, 1 ]
NCT02111850
24:30:chronic_disease,38:61:chronic_disease,92:111:chronic_disease,113:136:chronic_disease,161:172:chronic_disease,194:216:chronic_disease
Clinically significant atrial and or ventricular arrhythmias including but not limited to: atrial fibrillation, ventricular tachycardia, second or third degree heart block or have a history of ischemic heart disease, or chest pain
2
[ "Clinically", "significant", "atrial", "and", "or", "ventricular", "arrhythmias", "including", "but", "not", "limited", "to", ":", "atrial", "fibrillation", ",", "ventricular", "tachycardia", ",", "second", "or", "third", "degree", "heart", "block", "or", "have", ...
[ 0, 0, 2, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0 ]
NCT02021279
46:64:treatment
Subject is to planning to undergo concurrent surgical treatment of prolapse using mesh other than the MatriStem Pelvic Floor Matrix
2
[ "Subject", "is", "to", "planning", "to", "undergo", "concurrent", "surgical", "treatment", "of", "prolapse", "using", "mesh", "other", "than", "the", "MatriStem", "Pelvic", "Floor", "Matrix" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02597985
1:21:chronic_disease
Advanced Parkinson's
2
[ "Advanced", "Parkinson", "'s" ]
[ 2, 2, 0 ]
NCT01666080
1:16:treatment
Transplantation using sufficiently matched related donors (such as matched siblings) or unrelated donors
2
[ "Transplantation", "using", "sufficiently", "matched", "related", "donors", "(", "such", "as", "matched", "siblings", ")", "or", "unrelated", "donors" ]
[ 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02341300
,98:113:treatment,
Women with severe chronic illness and high likelihood of preterm birth and/or expected long-term hospitalizations during pregnancy
2
[ "Women", "with", "severe", "chronic", "illness", "and", "high", "likelihood", "of", "preterm", "birth", "and/or", "expected", "long-term", "hospitalizations", "during", "pregnancy" ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
NCT02189889
12:18:chronic_disease,
history of stroke within the last 6 months
2
[ "history", "of", "stroke", "within", "the", "last", "6", "months" ]
[ 0, 0, 2, 0, 0, 0, 0, 0 ]
NCT02187848
47:67:treatment
non-resolution of toxicities induced by these anticancer therapies
2
[ "non-resolution", "of", "toxicities", "induced", "by", "these", "anticancer", "therapies" ]
[ 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT01842399
10:13:treatment,
If their FSH test is more than 20, they will be considered menopausal
2
[ "If", "their", "FSH", "test", "is", "more", "than", "20", ",", "they", "will", "be", "considered", "menopausal" ]
[ 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02445768
27:33:chronic_disease
having ever experienced a stroke
2
[ "having", "ever", "experienced", "a", "stroke" ]
[ 0, 0, 0, 0, 2 ]
NCT02861417
22:36:treatment
Patients must have a haploidentical related donor or a fully matched related or unrelated donor
2
[ "Patients", "must", "have", "a", "haploidentical", "related", "donor", "or", "a", "fully", "matched", "related", "or", "unrelated", "donor" ]
[ 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02983240
1:20:chronic_disease
Severe preeclampsia
2
[ "Severe", "preeclampsia" ]
[ 2, 2 ]
NCT02410954
8:19:treatment,
Use of medications known to affect Central Nervous System (CNS) function within 5 half-lives screening
2
[ "Use", "of", "medications", "known", "to", "affect", "Central", "Nervous", "System", "(", "CNS", ")", "function", "within", "5", "half-lives", "screening" ]
[ 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03146663
,23:61:treatment
Received fewer than 3 prior chemotherapy-containing regimens
2
[ "Received", "fewer", "than", "3", "prior", "chemotherapy-containing", "regimens" ]
[ 0, 0, 0, 0, 1, 1, 1 ]
NCT03152409
12:20:chronic_disease
History of GI bleed
2
[ "History", "of", "GI", "bleed" ]
[ 0, 0, 2, 2 ]
NCT02516670
1:22:chronic_disease,24:34:treatment,36:46:treatment
Gastrointestinal (GI): cimetidine, aprepitant
2
[ "Gastrointestinal", "(", "GI", ")", ":", "cimetidine", ",", "aprepitant" ]
[ 2, 2, 0, 0, 0, 1, 0, 1 ]
NCT01817751
59:72:treatment
Any condition that would prohibit patient from initiating valproic acid
2
[ "Any", "condition", "that", "would", "prohibit", "patient", "from", "initiating", "valproic", "acid" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT01804465
11:17:cancer
Any other cancer from which the patient has been disease-free for 5 years
2
[ "Any", "other", "cancer", "from", "which", "the", "patient", "has", "been", "disease-free", "for", "5", "years" ]
[ 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01676753
43:82:allergy_name
Patient has known hypersensitivity to the components of study drug or its analogs
2
[ "Patient", "has", "known", "hypersensitivity", "to", "the", "components", "of", "study", "drug", "or", "its", "analogs" ]
[ 0, 0, 0, 0, 0, 0, 4, 4, 4, 4, 4, 4, 4 ]
NCT01742338
36:43:chronic_disease,45:61:chronic_disease,65:70:chronic_disease
Alternative diagnosis for cause of dyspnea, increased sputum or cough
2
[ "Alternative", "diagnosis", "for", "cause", "of", "dyspnea", ",", "increased", "sputum", "or", "cough" ]
[ 0, 0, 0, 0, 0, 2, 0, 2, 2, 0, 2 ]
NCT02515110
23:43:cancer,47:82:cancer,91:109:cancer,110:132:treatment
complete resection of basal cell carcinoma or squamous cell carcinoma of the skin and any in situ malignancy after curative therapy
2
[ "complete", "resection", "of", "basal", "cell", "carcinoma", "or", "squamous", "cell", "carcinoma", "of", "the", "skin", "and", "any", "in", "situ", "malignancy", "after", "curative", "therapy" ]
[ 0, 0, 0, 3, 3, 3, 0, 3, 3, 3, 3, 3, 3, 0, 0, 3, 3, 3, 1, 1, 1 ]
NCT02192398
17:39:treatment,49:61:treatment,78:89:chronic_disease,97:108:treatment
Subjects are on antihypertensive drugs (e.g., a beta-blocker) that result in hypotension and/or bradycardia as defined above
2
[ "Subjects", "are", "on", "antihypertensive", "drugs", "(", "e.g.", ",", "a", "beta-blocker", ")", "that", "result", "in", "hypotension", "and/or", "bradycardia", "as", "defined", "above" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0, 0, 0 ]
NCT01562626
1:21:chronic_disease
patent foramen ovale
2
[ "patent", "foramen", "ovale" ]
[ 2, 2, 2 ]
NCT02411656
13:23:cancer,36:49:cancer,58:78:cancer,82:117:cancer,130:145:cancer,177:193:treatment
Has a known malignancy (other than breast cancer) except basal cell carcinoma or squamous cell carcinoma of the skin, or in situ cervical cancer that has undergone potentially curative therapy
2
[ "Has", "a", "known", "malignancy", "(", "other", "than", "breast", "cancer", ")", "except", "basal", "cell", "carcinoma", "or", "squamous", "cell", "carcinoma", "of", "the", "skin", ",", "or", "in", "situ", "cervical", "cancer", "that", "has", "undergone", ...
[ 0, 0, 0, 3, 0, 0, 0, 3, 3, 0, 0, 3, 3, 3, 0, 3, 3, 3, 3, 3, 3, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 1, 1 ]
NCT02885649
1:33:chronic_disease
Retroperitoneal/hilar adenopathy concerning for locally advanced disease
2
[ "Retroperitoneal/hilar", "adenopathy", "concerning", "for", "locally", "advanced", "disease" ]
[ 2, 2, 0, 0, 0, 0, 0 ]
NCT03004287
22:42:cancer
Diagnosis of primary plasma cell leukemia
2
[ "Diagnosis", "of", "primary", "plasma", "cell", "leukemia" ]
[ 0, 0, 0, 3, 3, 3 ]
NCT02496663
15:30:treatment
Any number of prior therapies is allowed
2
[ "Any", "number", "of", "prior", "therapies", "is", "allowed" ]
[ 0, 0, 0, 1, 1, 0, 0 ]
NCT03135145
14:30:treatment
referred for physical therapy for mobility/gait training to regain functional walking and ambulation
2
[ "referred", "for", "physical", "therapy", "for", "mobility/gait", "training", "to", "regain", "functional", "walking", "and", "ambulation" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02501954
1:8:treatment,30:42:treatment,47:77:treatment
Surgery must have included a hysterectomy and bilateral salpingooophorectomy
2
[ "Surgery", "must", "have", "included", "a", "hysterectomy", "and", "bilateral", "salpingooophorectomy" ]
[ 1, 0, 0, 0, 0, 1, 0, 1, 1 ]
NCT02342782
1:24:chronic_disease,25:40:chronic_disease,44:71:chronic_disease
Active hepatitis B or C viral infection or hepatitis B surface antigen positive
2
[ "Active", "hepatitis", "B", "or", "C", "viral", "infection", "or", "hepatitis", "B", "surface", "antigen", "positive" ]
[ 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT03073070
12:39:chronic_disease
history of gastrointestinal blood loss
2
[ "history", "of", "gastrointestinal", "blood", "loss" ]
[ 0, 0, 2, 2, 2 ]
NCT02553447
31:64:treatment
Simultaneous participation in other therapeutic clinical trials will be allowed
2
[ "Simultaneous", "participation", "in", "other", "therapeutic", "clinical", "trials", "will", "be", "allowed" ]
[ 0, 0, 0, 1, 1, 1, 1, 0, 0, 0 ]
NCT03109431
13:26:chronic_disease
Established HIV infection (not acutely infected)
2
[ "Established", "HIV", "infection", "(", "not", "acutely", "infected", ")" ]
[ 0, 2, 2, 0, 0, 0, 0, 0 ]
NCT03065465
7:24:chronic_disease,,
Acute hypovolemic shock that is unresponsive to transfusion of 5 or more units of red blood cells (RBC's)
2
[ "Acute", "hypovolemic", "shock", "that", "is", "unresponsive", "to", "transfusion", "of", "5", "or", "more", "units", "of", "red", "blood", "cells", "(", "RBC", "'s", ")" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01983462
8:44:treatment,52:59:treatment,61:68:treatment,70:78:treatment,83:91:treatment,94:110:treatment,118:128:treatment,130:139:treatment,144:155:treatment,158:165:treatment
Taking Phosphodiesterase (PDE) 5 inhibitors (e.g., Viagra®, Cialis®, Levitra®, or Revatio®); PDE 3 inhibitors (e.g., cilostazol, milrinone, or vesnarinone); lithium
2
[ "Taking", "Phosphodiesterase", "(", "PDE", ")", "5", "inhibitors", "(", "e.g.", ",", "Viagra®", ",", "Cialis®", ",", "Levitra®", ",", "or", "Revatio®", ")", ";", "PDE", "3", "inhibitors", "(", "e.g.", ",", "cilostazol", ",", "milrinone", ",", "or", "vesn...
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
NCT02339922
31:49:chronic_disease,64:75:chronic_disease,79:80:chronic_disease,81:96:chronic_disease,107:141:chronic_disease
Known ongoing or known active systemic infection, known active hepatitis B or C virus infection, or known human immunodeficiency virus (HIV) positive
2
[ "Known", "ongoing", "or", "known", "active", "systemic", "infection", ",", "known", "active", "hepatitis", "B", "or", "C", "virus", "infection", ",", "or", "known", "human", "immunodeficiency", "virus", "(", "HIV", ")", "positive" ]
[ 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 2, 2, 0, 2, 2, 2, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0 ]
NCT02213068
1:4:chronic_disease
EBV seropositive
2
[ "EBV", "seropositive" ]
[ 2, 0 ]
NCT02016235
54:88:chronic_disease,110:129:chronic_disease,,,164:180:chronic_disease,199:217:treatment,219:234:treatment,239:248:treatment,
Exclusion criteria include history of symptomatic or asymptomatic kidney stone disease; primary or secondary hyperparathyroidism; estimated GFR <40 ml/min/1.73m2, chronic diarrhea states; intake of thiazide diuretics, glucocorticoids, or estrogens within one month of the study
2
[ "Exclusion", "criteria", "include", "history", "of", "symptomatic", "or", "asymptomatic", "kidney", "stone", "disease", ";", "primary", "or", "secondary", "hyperparathyroidism", ";", "estimated", "GFR", "<", "40", "ml/min/1.73m2", ",", "chronic", "diarrhea", "states...
[ 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 1, 1, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0 ]
NCT02004275
24:59:treatment,47:59:treatment,61:71:treatment,76:89:treatment,175:201:treatment,,320:328:treatment
A patient who receives induction therapy with lenalidomide, bortezomib and dexamethasone and achieves a PR or better but subsequently progresses on continued lenalidomide or lenalidomide-dexamethasone would be eligible provided the progression occurs 60 days or more after discontinuation of the bortezomib; similarly, i...
2
[ "A", "patient", "who", "receives", "induction", "therapy", "with", "lenalidomide", ",", "bortezomib", "and", "dexamethasone", "and", "achieves", "a", "PR", "or", "better", "but", "subsequently", "progresses", "on", "continued", "lenalidomide", "or", "lenalidomide-de...
[ 0, 0, 0, 0, 1, 1, 1, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02266329
26:67:treatment
Current participation in transcranial magnetic stimulation studies
2
[ "Current", "participation", "in", "transcranial", "magnetic", "stimulation", "studies" ]
[ 0, 0, 0, 1, 1, 1, 1 ]
NCT02346253
51:69:treatment,
Clinically negative lymph nodes as established by abdomino-pelvic CT, no more than 90 days prior toregistration
2
[ "Clinically", "negative", "lymph", "nodes", "as", "established", "by", "abdomino-pelvic", "CT", ",", "no", "more", "than", "90", "days", "prior", "toregistration" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01849146
21:43:treatment
receiving any other investigational agents are ineligible
2
[ "receiving", "any", "other", "investigational", "agents", "are", "ineligible" ]
[ 0, 0, 0, 1, 1, 0, 0 ]
NCT02101034
27:40:treatment,45:63:cancer,86:95:treatment
Phase I only: any (or no) prior therapy for metastatic disease is allowed, including cetuximab
2
[ "Phase", "I", "only", ":", "any", "(", "or", "no", ")", "prior", "therapy", "for", "metastatic", "disease", "is", "allowed", ",", "including", "cetuximab" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 3, 3, 0, 0, 0, 0, 1 ]
NCT02188745
1:23:chronic_disease
deep venous thrombosis
2
[ "deep", "venous", "thrombosis" ]
[ 2, 2, 2 ]
NCT02140554
18:30:treatment
Prior receipt of gene therapy
2
[ "Prior", "receipt", "of", "gene", "therapy" ]
[ 0, 0, 0, 1, 1 ]
NCT02522715
,52:81:treatment,85:111:treatment,115:127:treatment,
Must have appropriate wash out (> 6 half-lives) of androgen receptor antagonists, 5 alpha reductase inhibitors or ketoconazole prior to the start of cycle 1; if the agent is not in the table below, the washout should be 2 weeks
2
[ "Must", "have", "appropriate", "wash", "out", "(", ">", "6", "half-lives", ")", "of", "androgen", "receptor", "antagonists", ",", "5", "alpha", "reductase", "inhibitors", "or", "ketoconazole", "prior", "to", "the", "start", "of", "cycle", "1", ";", "if", "...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 1, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02914509
25:44:chronic_disease,,,98:117:chronic_disease,126:143:chronic_disease,181:206:chronic_disease
Documented diagnosis of ocular hypertension with an open angle of Schaffer Grade 3 or greater or open-angle glaucoma without pseudoexfoliation or pigment dispersion or evidence of traumatic angle recession
2
[ "Documented", "diagnosis", "of", "ocular", "hypertension", "with", "an", "open", "angle", "of", "Schaffer", "Grade", "3", "or", "greater", "or", "open-angle", "glaucoma", "without", "pseudoexfoliation", "or", "pigment", "dispersion", "or", "evidence", "of", "traum...
[ 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 2, 0, 0, 0, 0, 0, 0, 2, 2, 2 ]
NCT02362308
1:17:chronic_disease
Type II Diabetes, as defined by ADA criteria
2
[ "Type", "II", "Diabetes", ",", "as", "defined", "by", "ADA", "criteria" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT01434316
28:67:cancer,,163:172:treatment,181:198:treatment
patients with a history of central nervous system (CNS) metastases that have been treated must be stable with no symptoms for > 3 months after completion of that treatment and off steroid treatment, with image documentation required prior to study enrollment
2
[ "patients", "with", "a", "history", "of", "central", "nervous", "system", "(", "CNS", ")", "metastases", "that", "have", "been", "treated", "must", "be", "stable", "with", "no", "symptoms", "for", ">", "3", "months", "after", "completion", "of", "that", "t...
[ 0, 0, 0, 0, 0, 3, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02993406
1:32:chronic_disease
transient ischemic attack (TIA)
2
[ "transient", "ischemic", "attack", "(", "TIA", ")" ]
[ 2, 2, 2, 2, 0, 0 ]
NCT02500147
30:46:chronic_disease
Past or present history of a medical disorder or medication known to affect body composition
2
[ "Past", "or", "present", "history", "of", "a", "medical", "disorder", "or", "medication", "known", "to", "affect", "body", "composition" ]
[ 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02181257
,81:122:chronic_disease,161:164:chronic_disease,173:182:chronic_disease,184:197:chronic_disease
Patients whose decline in lung function (FEV1) is related to either Restrictive Chronic Lung Allograft Dysfunction (CLAD) or other causes that do not represent BOS such as pneumonia, heart failure, etc
2
[ "Patients", "whose", "decline", "in", "lung", "function", "(", "FEV1", ")", "is", "related", "to", "either", "Restrictive", "Chronic", "Lung", "Allograft", "Dysfunction", "(", "CLAD", ")", "or", "other", "causes", "that", "do", "not", "represent", "BOS", "su...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 2, 0, 2, 2, 0, 0 ]
NCT02266745
14:38:chronic_disease,,,,99:120:chronic_disease,122:146:chronic_disease,148:195:treatment,197:222:chronic_disease,227:245:chronic_disease,,285:295:treatment
Uncontrolled congestive heart failure (New York Heart Association Classification 3 or 4), angina, myocardial infarction, cerebrovascular accident, coronary/peripheral artery bypass graft surgery, transient ischemic attack, or pulmonary embolism within 3 months prior to initiation of study drug
2
[ "Uncontrolled", "congestive", "heart", "failure", "(", "New", "York", "Heart", "Association", "Classification", "3", "or", "4", ")", ",", "angina", ",", "myocardial", "infarction", ",", "cerebrovascular", "accident", ",", "coronary/peripheral", "artery", "bypass", ...
[ 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 2, 2, 0, 1, 1, 1, 1, 1, 0, 2, 2, 2, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02374021
7:51:chronic_disease,58:84:chronic_disease,86:97:chronic_disease
other autoimmune and chronic inflammatory diseases (i.e. inflammatory bowel disease, sarcoidosis)
2
[ "other", "autoimmune", "and", "chronic", "inflammatory", "diseases", "(", "i.e", ".", "inflammatory", "bowel", "disease", ",", "sarcoidosis", ")" ]
[ 0, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 2, 0 ]
NCT01695967
1:19:chronic_disease
bleeding disorders
2
[ "bleeding", "disorders" ]
[ 2, 2 ]
NCT02411318
18:29:treatment
Currently taking medications that are not recommended to be taken in conjunction with alcohol
2
[ "Currently", "taking", "medications", "that", "are", "not", "recommended", "to", "be", "taken", "in", "conjunction", "with", "alcohol" ]
[ 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02762825
39:52:chronic_disease,
Any patient recently hospitalized for heart failure will have to wait at least 2 weeks before starting CR
2
[ "Any", "patient", "recently", "hospitalized", "for", "heart", "failure", "will", "have", "to", "wait", "at", "least", "2", "weeks", "before", "starting", "CR" ]
[ 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02838797
1:9:chronic_disease,,
Dementia (Mini Mental Status Exam < 25)
2
[ "Dementia", "(", "Mini", "Mental", "Status", "Exam", "<", "25", ")" ]
[ 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01822522
1:25:chronic_disease
Cardiovascular disorders
2
[ "Cardiovascular", "disorders" ]
[ 2, 2 ]
NCT02565199
49:52:treatment
The subjects must be comfortable when receiving TMS of all strengths
2
[ "The", "subjects", "must", "be", "comfortable", "when", "receiving", "TMS", "of", "all", "strengths" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0 ]